Presentation TCT 2019

Study Design Considerations for HBR Patients in Japan

Presenter: Yasuko Nakamura

September 26, 2019

REGISTER for free or LOG IN to view this content

Study Design Considerations for HBR Patients in Japan

Policy & Practice

Presentation

TCT 2019

Up Next

Presentation TCT 2019

PCI for HBD Patients in Japan: Current Clinical Treatment and Post-Market Treatment

Presenter: Junya Ako

September 26, 2019

More slides +

Presentation TCT 2019

ARC Definition of High Bleeding Risk: Global Impact on HBR PCI Clinical Studies?

Presenter: Hans-Peter Stoll

September 26, 2019

Presentation TCT 2019

Study Design Considerations for HBR Patients and DES Platforms: FDA View

Presenter: Adrian Magee

September 26, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.